Showing results (61-70 of 91) with videos related to
Sort By:
Pageof 10
Journal of Clinical Lipidology|January 15, 2013
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studiesEli M Roth, Robert S Rosenson, Peter H Jones, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2010
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trialsPeter H Jones, Kenneth Cusi, Michael H Davidson, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2009
CD11c expression in adipose tissue and blood and its role in diet-induced obesityHuaizhu Wu, Xiaoyuan Dai Perrard, Qun Wang, et al.The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Eotaxin and obesityAbu R Vasudevan, Huaizhu Wu, Antonios M Xydakis, et al.The American Journal of Cardiology|July 16, 2003
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)Peter H Jones, Michael H Davidson, Evan A Stein, et al.Journal of Lipid Research|December 2, 2008
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markersThomas M van Himbergen, Nirupa R Matthan, Nancy A Resteghini, et al.JAMA|September 8, 2005
Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trialMichael Fordis, Jason E King, Christie M Ballantyne, et al.Clinical Drug Investigation|September 12, 2008
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programmePeter H Jones, Harold E Bays, Michael H Davidson, et al.Journal of Clinical Lipidology|January 29, 2013
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier diseaseSmita I Negi, Ariel Brautbar, Salim S Virani, et al.Data in Brief|April 8, 2016
A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management GuidelineYashashwi Pokharel, Lynne Steinberg, Winston Chan, et al.Pageof 10